Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "R03A" (83)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Salbutamol (R03AC02) 9 products
WHO-DDD
DrugBank.ca
IP
CI
Salamol Autohaler
200 inhalation(s)
9.76
27.05
10 %
Metered dose aerosol: Salbutamolum
Teva Pharma AG
● 
B / SL
FB
G
IP
CI
Ventolin
200
4.03
13.60
10 %
Metered dose aerosol: Salbutamolum 100 µg
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Ventolin 5 mg/ml
20 ml
4.34
13.95
10 %
Inhalation solution: Salbutamolum 5 mg/ml
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Salbu Orion Easyhaler 100
200 unidose(s)
5.05
14.75
10 %
Inhalation Powder: Salbutamolum 100 µg
Orion Pharma AG
B / SL
FB
G
IP
CI
Salbu Orion Easyhaler 200
200 unidose(s)
10.10
27.40
10 %
Inhalation Powder: Salbutamolum 200 µg
Orion Pharma AG
B / SL
FB
G
IP
CI
Ventolin Diskus
60 unidose(s)
7.32
17.20
10 %
Multidosen-Pulverinhalator: Salbutamolum 200 µg
GlaxoSmithKline AG
B / SL
FB
G
IP
Ventolin 0.5 mg/ml
5 1 ampoule(s) à 1 ml
PR
PR
k.A.
Injection solution: Salbutamolum
GlaxoSmithKline AG
B
FB
G
IP
Ventolin 1 mg/ml
5 1 ampoule(s) à 5 ml
PR
PR
k.A.
Concentrate for infusion: Salbutamolum 5mg / 5ml
GlaxoSmithKline AG
B
FB
G
Airomir
200 unidose(s)
9.40
21.30
k.A.
Metered dose aerosol: Salbutamolum
3M (Schweiz) GmbH
B
FB
G
Terbutaline (R03AC03) 3 products
WHO-DDD
DrugBank.ca
IP
CI
Bricanyl Turbuhaler
120
7.09
16.95
10 %
Pulver mit Applikator: Terbutalini Sulfas 500 µg
AstraZeneca AG
B / SL
FB
G
IP
CI
Bricanyl
400 unidose(s)
11.91
26.30
k.A.
Metered dose aerosol: Terbutalini Sulfas
AstraZeneca AG
B
FB
G
IP
CI
Bricanyl
20 ml
6.11
15.40
k.A.
Inhalation solution: Terbutalini Sulfas 10 mg
AstraZeneca AG
B
FB
G
Salmeterol (R03AC12) 2 products
WHO-DDD
DrugBank.ca
IP
CI
Serevent
120
34.51
53.95
10 %
Metered dose aerosol: Salmeterolum 25 µg
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Serevent Diskus
60 1 inhalation(s) à 50 ug
34.51
53.95
10 %
Multidosen-Pulverinhalator: Salmeterolum 50 µg
GlaxoSmithKline AG
B / SL
FB
G
Formoterol (R03AC13) 3 products
WHO-DDD
DrugBank.ca
IP
CI
Oxis 6 Turbuhaler
60 unidose(s)
16.39
34.25
10 %
Inhalation Powder: Formoteroli Fumaras Dihydricus 6 µg
AstraZeneca AG
B / SL
FB
G
IP
CI
Oxis 12 Turbuhaler
60 unidose(s)
21.48
39.80
10 %
Inhalation Powder: Formoteroli Fumaras Dihydricus 12 µg
AstraZeneca AG
B / SL
FB
G
IP
CI
Foradil 12 mcg
60 Capsule(s)
27.21
46.00
10 %
Trockenpulver-Kapseln zur Inhalation: Formoteroli Fumaras Dihydricus 12 µg
Sandoz
Pharmaceuticals AG
B / SL
FB
G
Indacaterol (R03AC18) 6 products
WHO-DDD
DrugBank.ca
IP
CI
PP
Onbrez Breezhaler 150 mcg
30 Capsule(s)
35.06
54.55
10 %
Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Active Agents
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
PP
Onbrez Breezhaler 300 mcg
30 Capsule(s)
41.12
61.15
10 %
Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Active Agents
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
PP
Onbrez Breezhaler 150 mcg
90 Capsule(s)
89.40
113.65
10 %
Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Active Agents
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
PP
Onbrez Breezhaler 300 mcg
90 Capsule(s)
104.88
130.50
10 %
Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Active Agents
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
PP
Onbrez Breezhaler 150 mcg
90 Capsule(s)
PR
PR
k.A.
Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Active Agents
Novartis Pharma
Schweiz AG
B
FB
G
IP
CI
PP
Onbrez Breezhaler 300 mcg
90 Capsule(s)
PR
PR
k.A.
Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Active Agents
Novartis Pharma
Schweiz AG
B
FB
G
Olodaterol (R03AC19) 2 products
WHO-DDD
DrugBank.ca
IP
CI
Striverdi Respimat 2.5 mcg
32.51
51.75
10 %
Lösung zur Inhalation (wiederverwendbar): Olodaterolum 2.5 µg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
IP
CI
Striverdi Respimat 2.5 mcg
3
97.53
122.50
10 %
Lösung zur Inhalation (wiederverwendbar): Olodaterolum 2.5 µg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
Salmeterol and Fluticasone (R03AK06) 9 products
WHO-DDD
DrugBank.ca
IP
CI
Seretide 50
120 unidose(s)
33.32
52.65
10 %
Metered dose aerosol: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Seretide 125
120 unidose(s)
48.40
69.05
10 %
Metered dose aerosol: 2 Active Agents
GlaxoSmithKline AG
● 
B / SL
FB
G
IP
CI
Seretide 250
120 unidose(s)
71.88
94.60
10 %
Metered dose aerosol: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
Seretide Diskus 100
60 unidose(s)
32.15
51.40
10 %
Multidosen-Pulverinhalator: 2 Active Agents
GlaxoSmithKline AG
● 
B / SL
FB
G
IP
CI
Seretide Diskus 250
60 unidose(s)
46.70
67.20
10 %
Multidosen-Pulverinhalator: 2 Active Agents
GlaxoSmithKline AG
● 
B / SL
FB
G
IP
CI
Seretide Diskus 500
60 unidose(s)
69.36
91.85
10 %
Multidosen-Pulverinhalator: 2 Active Agents
GlaxoSmithKline AG
● 
B / SL
FB
G
IP
CI
Seffalair Spiromax 55/14 mcg
60
25.72
44.40
10 %
Multidosenpulverinhalator: 2 Active Agents
Teva Pharma AG
B / SL
FB
G
IP
Seffalair Spiromax 113/14 mcg
60
37.36
57.05
10 %
Multidosenpulverinhalator: 2 Active Agents
Teva Pharma AG
B / SL
FB
G
IP
Seffalair Spiromax 232/14 mcg
60
55.49
76.75
10 %
Multidosenpulverinhalator: 2 Active Agents
Teva Pharma AG
B / SL
FB
G
Formoterol and Budesonide (R03AK07) 7 products
WHO-DDD
DrugBank.ca
IP
CI
Vannair 100/6
120 unidose(s)
42.16
62.25
10 %
Metered dose aerosol: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
IP
CI
Vannair 200/6
120 unidose(s)
47.90
68.50
10 %
Metered dose aerosol: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
IP
CI
Symbicort 100/6
Turbuhaler
60 unidose(s)
22.40
40.80
10 %
Inhalation Powder: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
IP
CI
Symbicort 100/6
Turbuhaler
120 unidose(s)
39.38
59.25
10 %
Inhalation Powder: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
IP
CI
Symbicort 200/6
Turbuhaler
60 unidose(s)
25.44
44.10
10 %
Inhalation Powder: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
IP
CI
Symbicort 200/6
Turbuhaler
120 unidose(s)
44.74
65.05
10 %
Inhalation Powder: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
IP
CI
Symbicort 400/12
Turbuhaler
60 unidose(s)
40.84
60.85
10 %
Inhalation Powder: 2 Active Agents
AstraZeneca AG
B / SL
FB
G
Formoterol and Beclometasone (R03AK08) 3 products
WHO-DDD
DrugBank.ca
IP
CI
Foster 100 μg / 6 μg
120
48.00
68.60
10 %
Solution pour inhalation en flacon pressurisé: 2 Active Agents
Chiesi SA
B / SL
FB
G
IP
Foster 200 μg / 6 μg
120
49.01
69.70
10 %
solution pour inhalation en flacon pressurisé: 2 Active Agents
Chiesi SA
B / SL
FB
G
IP
CI
Foster 100 μg / 6 μg
240
PR
PR
k.A.
Solution pour inhalation en flacon pressurisé: 2 Active Agents
Chiesi SA
B
FB
G
Vilanterol and Fluticasone Furoate (R03AK10) 4 products
WHO-DDD
DrugBank.ca
IP
CI
PP
Relvar Ellipta 92/22 mcg
30 unidose(s)
30.67
49.75
10 %
Einzeldosiertes Pulver zur Inhalation: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
PP
Relvar Ellipta 92/22 mcg
3 x 30
92.01
116.50
10 %
Einzeldosiertes Pulver zur Inhalation: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
PP
Relvar Ellipta 184/22 mcg
30 unidose(s)
38.90
58.70
10 %
Einzeldosiertes Pulver zur Inhalation: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
PP
Relvar Ellipta 184/22 mcg
3 x 30
116.70
143.35
10 %
Einzeldosiertes Pulver zur Inhalation: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
Formoterol and Fluticasone (R03AK11) 3 products
WHO-DDD
DrugBank.ca
IP
CI
Flutiform 50/5
120
30.89
50.00
10 %
Druckgasinhalation: 2 Active Agents
Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch
B / SL
FB
G
IP
CI
Flutiform 125/5
120
41.27
61.30
10 %
Druckgasinhalation: 2 Active Agents
Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch
B / SL
FB
G
IP
CI
Flutiform 250/10
120
58.69
80.25
10 %
Druckgasinhalation: 2 Active Agents
Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch
B / SL
FB
G
Indacaterol and Mometasone (R03AK14) 6 products
WHO-DDD
IP
Atectura Breezhaler
150/80 μg
30
32.28
51.50
10 %
Inhalation Powder: Indacaterolum
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
Atectura Breezhaler
150/160 μg
30
32.28
51.50
10 %
Inhalation Powder: Indacaterolum
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
Atectura Breezhaler
150/320 μg
30
32.28
51.50
10 %
Inhalation Powder: Indacaterolum
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
Atectura Breezhaler
150/80 μg
90
96.74
121.65
10 %
Inhalation Powder: Indacaterolum
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
Atectura Breezhaler
150/160 μg
90
96.74
121.65
10 %
Inhalation Powder: Indacaterolum
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
Atectura Breezhaler
150/320 μg
90
96.74
121.65
10 %
Inhalation Powder: Indacaterolum
Novartis Pharma
Schweiz AG
B / SL
FB
G
Fenoterol and Ipratropium Bromide (R03AL01) 1 products
WHO-DDD
DrugBank.ca
IP
CI
Berodual N
200 inhalation(s)
12.21
29.70
10 %
Metered dose aerosol: 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
Salbutamol and Ipratropium Bromide (R03AL02) 3 products
WHO-DDD
DrugBank.ca
IP
CI
Dospir
60 unidose(s)
16.00
33.70
10 %
Lösung für einen Vernebler (Einzeldosen): 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL / SO
FB
G
IP
CI
Ipramol Steri-Nebs
60 unidose(s)
14.40
32.10
10 %
Inhalation solution: 2 Active Agents
Teva Pharma AG
● 
B / SL / SG
FB
G
IP
CI
Dospir
20 unidose(s)
PR
PR
k.A.
Lösung für einen Vernebler (Einzeldosen): 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B
FB
G
Vilanterol and Umeclidinium Bromide (R03AL03) 2 products
WHO-DDD
DrugBank.ca
IP
CI
PP
Anoro Ellipta 55 mcg/22 mcg
30 unidose(s)
44.48
64.80
10 %
Einzeldosiertes Pulver zur Inhalation: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
IP
CI
PP
Anoro Ellipta 55 mcg/22 mcg
3 x 30 unidose(s)
133.45
161.55
10 %
Einzeldosiertes Pulver zur Inhalation: 2 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
Indacaterol and Glycopyrronium Bromide (R03AL04) 2 products
WHO-DDD
DrugBank.ca
IP
CI
PP
Ultibro Breezhaler 110/50
30 Capsule(s)
45.57
66.00
10 %
Inhalation Powder: 2 Active Agents
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
PP
Ultibro Breezhaler 110/50
90
136.55
164.90
10 %
Inhalation Powder: 2 Active Agents
Novartis Pharma
Schweiz AG
B / SL
FB
G
Olodaterol and Tiotropium Bromide (R03AL06) 2 products
WHO-DDD
DrugBank.ca
IP
CI
Spiolto Respimat 2.5 mcg / 2.5 mcg
46.84
67.35
10 %
Lösung zur Inhalation (wiederverwendbar): 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
IP
CI
Spiolto Respimat 2.5 mcg / 2.5 mcg
3
140.52
169.25
10 %
Lösung zur Inhalation (wiederverwendbar): 2 Active Agents
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
Vilanterol, Umeclidinium Bromide and Fluticasone Furoate (R03AL08) 2 products
WHO-DDD
L
IP
CI
Trelegy Ellipta
30
64.92
87.00
10 %
Einzeldosiertes Pulver zur Inhalation: 3 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
L
IP
CI
Trelegy Ellipta
3 x 30
194.75
228.20
10 %
Einzeldosiertes Pulver zur Inhalation: 3 Active Agents
GlaxoSmithKline AG
B / SL
FB
G
Formoterol, Glycopyrronium Bromide and Beclometasone (R03AL09) 9 products
WHO-DDD
Trimbow 88/5/9
120
PR
PR
k.A.
poudre pour inhalation: 3 Active Agents
Chiesi SA
B
FB
G
Trimbow 88/5/9
360
PR
PR
k.A.
poudre pour inhalation: 3 Active Agents
Chiesi SA
B
FB
G
L
IP
Trimbow 172/5/9 mcg
62.07
83.90
10 %
Chiesi SA
B / SL
FB
G
L
IP
Trimbow 172/5/9 mcg
360
185.63
218.30
10 %
Chiesi SA
B / SL
FB
G
L
IP
CI
Trimbow 87/5/9 mcg
120
57.99
79.50
10 %
solution pour inhalation en flacon pressurisé: 3 Active Agents
Chiesi SA
B / SL
FB
G
L
IP
CI
Trimbow 87/5/9 mcg
360
173.39
205.00
10 %
solution pour inhalation en flacon pressurisé: 3 Active Agents
Chiesi SA
B / SL
FB
G
IP
Trimbow 172/5/9 mcg
PR
PR
k.A.
Chiesi SA
B
FB
G
IP
Trimbow 172/5/9 mcg
240
PR
PR
k.A.
Chiesi SA
B
FB
G
IP
CI
Trimbow 87/5/9 mcg
60
PR
PR
k.A.
solution pour inhalation en flacon pressurisé: 3 Active Agents
Chiesi SA
B
FB
G
Formoterol, Glycopyrronium Bromide and Budesonide (R03AL11) 2 products
WHO-DDD
L
IP
CI
Trixeo Aerosphere
5/7.2/160 μg
120
61.59
83.40
10 %
AstraZeneca AG
B / SL
FB
G
L
IP
CI
Trixeo Aerosphere
5/7.2/160 μg
360
184.77
217.35
10 %
AstraZeneca AG
B / SL
FB
G
Indacaterol, Glycopyrronium Bromide and Mometasone (R03AL12) 3 products
WHO-DDD
L
IP
CI
Enerzair Breezhaler
150/50/160 μg
30
63.11
85.05
10 %
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Enerzair Breezhaler
150/50/160 μg
90
189.33
222.30
10 %
Novartis Pharma
Schweiz AG
B / SL
FB
G
IP
CI
Enerzair Breezhaler
150/50/160 μg
30
63.11
85.05
k.A.
Novartis Pharma
Schweiz AG
B
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home